Owens Daniel E. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Sep 2, 2022
Insider Transaction Report
Form 4
Owens Daniel E.
Chief HR Officer
Transactions
- Sale
Common Stock
2022-09-01$19.50/sh−1,000$19,502→ 10,700 total - Exercise/Conversion
Common Stock
2022-09-02$7.02/sh+1,500$10,531→ 12,200 total - Exercise/Conversion
Common Stock
2022-09-01$7.03/sh+1,000$7,028→ 11,700 total - Sale
Common Stock
2022-09-02$20.04/sh−1,500$30,060→ 10,700 total - Exercise/Conversion
Stock Option Right to Buy
2022-09-01−1,000→ 194,125 totalExercise: $7.03Exp: 2031-02-02→ Common Stock (1,000 underlying) - Exercise/Conversion
Stock Option Right to Buy
2022-09-02−1,500→ 192,625 totalExercise: $7.03Exp: 2031-02-02→ Common Stock (1,500 underlying)
Footnotes (4)
- [F1]Includes 6,700 RSUs.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.1600 to $19.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.